A open label, single arm multicenter study investigating the effect of bevacizumab + 5-fluorouracil, irinotecan, and leucovorin in patients from China with metastatic colorectal cancer

Trial Profile

A open label, single arm multicenter study investigating the effect of bevacizumab + 5-fluorouracil, irinotecan, and leucovorin in patients from China with metastatic colorectal cancer

Completed
Phase of Trial: Phase IV

Latest Information Update: 06 Dec 2015

At a glance

  • Drugs Bevacizumab (Primary) ; Fluorouracil; Folinic acid; Irinotecan
  • Indications Colorectal cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 06 Dec 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top